Rating History for Reata Pharmaceuticals (RETA) by TD Cowen

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/1/2023 Tyler Van Buren Maintain Buy
(N/A)
172.50
(140.00)
 
 
  Details